Levetiracetam Hormosan

Levetiracetam, the active ingredient in Levetiracetam Hormosan, is an anticonvulsant presented as an oral tablet for oral use. It is employed to control various types of epileptic seizures in adult and pediatric patients, reducing neuronal hyper‑excitability, and is approved in the European Union and widely prescribed in neurology practice.

GNH USA supplies Levetiracetam Hormosan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across markets.

Levetiracetam is used to manage seizure disorders by stabilizing neuronal activity.

- Partial seizures: reduces frequency of focal onset seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Myoclonic seizures: decreases occurrence of sudden muscle jerks.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: persistent tiredness or lack of energy. - Headache: mild to moderate cranial pain. - Nausea: feeling of stomach upset or urge to vomit.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression, anxiety, or suicidal thoughts. - Blood disorders: thrombocytopenia or leukopenia.

When prescribing Levetiracetam, clinicians should consider several safety measures.

- Renal impairment: adjust dose or monitor renal function. - Hepatic dysfunction: evaluate liver enzymes before initiation. - Concomitant CNS depressants: monitor for enhanced sedation. - Pregnancy: limited data, weigh benefits against potential risks. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in original container.

Levetiracetam can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: may lower levetiracetam exposure. - Phenytoin: can decrease levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Alcohol: may increase central nervous system depression. - Other antiepileptics (e.g., valproate): monitor for additive side effects. - Oral contraceptives: may have reduced effectiveness, advise alternative contraception.